Trial Profile
Withdrawal-Related Dysphoria as a Moderator of Ibudilast for Alcohol Use Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2022
Price :
$35
*
At a glance
- Drugs Ibudilast (Primary)
- Indications Alcohol withdrawal; Alcoholism
- Focus Therapeutic Use
- 05 Dec 2022 Results a secondary analysis of the study published in the MediciNova Media Release.
- 05 Dec 2022 According to a MediciNova media release, results from a secondary analysis of the study were published in The American Journal of Drug and Alcohol Abuse.
- 07 Apr 2022 According to a MediciNova media release, results of secondary analysis was published in the journal Alcoholism: Clinical and Experimental Research.